SG11202107901QA - Isolated cell culture components and methods for isolating the same from liquid cell culture medium - Google Patents

Isolated cell culture components and methods for isolating the same from liquid cell culture medium

Info

Publication number
SG11202107901QA
SG11202107901QA SG11202107901QA SG11202107901QA SG11202107901QA SG 11202107901Q A SG11202107901Q A SG 11202107901QA SG 11202107901Q A SG11202107901Q A SG 11202107901QA SG 11202107901Q A SG11202107901Q A SG 11202107901QA SG 11202107901Q A SG11202107901Q A SG 11202107901QA
Authority
SG
Singapore
Prior art keywords
cell culture
isolating
methods
same
culture medium
Prior art date
Application number
SG11202107901QA
Inventor
Deborah Lee Bitterfield
Michael Quinn DOHERTY
Original Assignee
Lindy Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lindy Biosciences Inc filed Critical Lindy Biosciences Inc
Publication of SG11202107901QA publication Critical patent/SG11202107901QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/10Separation or concentration of fermentation products
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/06Hydrolysis; Cell lysis; Extraction of intracellular or cell wall material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02Separating microorganisms from their culture media
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/145Extraction; Separation; Purification by extraction or solubilisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/08Homogenizing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12Purification

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG11202107901QA 2019-02-05 2020-02-05 Isolated cell culture components and methods for isolating the same from liquid cell culture medium SG11202107901QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962801225P 2019-02-05 2019-02-05
PCT/US2020/016743 WO2020163446A1 (en) 2019-02-05 2020-02-05 Isolated cell culture components and methods for isolating the same from liquid cell culture medium

Publications (1)

Publication Number Publication Date
SG11202107901QA true SG11202107901QA (en) 2021-08-30

Family

ID=71947933

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202107901QA SG11202107901QA (en) 2019-02-05 2020-02-05 Isolated cell culture components and methods for isolating the same from liquid cell culture medium

Country Status (9)

Country Link
US (2) US20220119760A1 (en)
EP (1) EP3921082A4 (en)
JP (1) JP2022519690A (en)
KR (1) KR20210125032A (en)
CN (1) CN113661006A (en)
AU (1) AU2020219125A1 (en)
CA (1) CA3128204A1 (en)
SG (1) SG11202107901QA (en)
WO (1) WO2020163446A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202107901QA (en) 2019-02-05 2021-08-30 Lindy Biosciences Inc Isolated cell culture components and methods for isolating the same from liquid cell culture medium
CN112675935B (en) * 2021-01-22 2022-03-25 中国科学院上海微系统与信息技术研究所 Droplet array chip for single cell freezing and droplet generation method and application

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030143659A1 (en) * 1996-03-28 2003-07-31 Hendrik Louis Bijl Process for the preparation of a granular microbial biomass and isolation of a compound thereform
IN184589B (en) 1996-10-16 2000-09-09 Alza Corp
US6080844A (en) * 1998-04-23 2000-06-27 Abbott Laboratories Process for the recovery and purification of a recombinant protein from a cell
GB9910975D0 (en) 1999-05-13 1999-07-14 Univ Strathclyde Rapid dehydration of proteins
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
DK2526996T3 (en) 2002-12-20 2019-12-02 Xeris Pharmaceuticals Inc Formulation for intracutaneous injection
US20050186183A1 (en) * 2003-12-08 2005-08-25 Deangelo Joseph Stabilized products, processes and devices for preparing same
EP1753404A1 (en) 2004-05-12 2007-02-21 Baxter International Inc. Microspheres comprising protein and showing injectability at high concentrations of said agent
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
US20060141040A1 (en) 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
AU2006332680A1 (en) * 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
MX2009003661A (en) 2006-10-06 2009-04-22 Baxter Int Microencapsules containing surface-modified microparticles and methods of forming and using the same.
US20090022727A1 (en) 2007-01-26 2009-01-22 Alza Corp. Injectable, nonaqueous suspension with high concentration of therapeutic agent
WO2008133908A2 (en) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
GB0707938D0 (en) 2007-04-25 2007-05-30 Univ Strathclyde Precipitation stabilising compositions
US8709827B2 (en) 2007-06-28 2014-04-29 Surmodics, Inc. Polypeptide microparticles
US8598378B2 (en) 2008-03-14 2013-12-03 University Of Hawaii Methods and compositions for extraction and transesterification of biomass components
US20100009007A1 (en) 2008-07-10 2010-01-14 Baxter International Inc. Non-covalent modification of microparticles and process of preparing same
CN102164597B (en) 2008-09-04 2014-09-03 安米林药品有限责任公司 Sustained release formulations using non-aqueous carriers
AU2009303905B2 (en) 2008-10-15 2015-01-22 Intarcia Therapeutics, Inc. Highly concentrated drug particles, formulations, suspensions and uses thereof
EP2376522A4 (en) 2008-11-16 2013-12-25 Univ Texas Low viscosity highly concentrated suspensions
WO2010100564A2 (en) 2009-03-02 2010-09-10 Assistance Publique - Hopitaux De Paris Injectable biomaterial
KR102176554B1 (en) * 2009-06-04 2020-11-09 게노마티카 인코포레이티드 Process of separating components of a fermentation broth
US9072668B2 (en) 2010-03-09 2015-07-07 Janssen Biotech, Inc. Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
US20110223208A1 (en) 2010-03-09 2011-09-15 Beth Hill Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
MX2012011562A (en) 2010-04-06 2013-04-03 Heliae Dev Llc Methods of and systems for producing biofuels.
WO2012012460A1 (en) 2010-07-19 2012-01-26 Xeris Pharmaceuticals, Inc. Stable glucagon formulations for the treatment of hypoglycemia
BR112013023062B1 (en) 2011-03-10 2022-01-18 Xeris Pharmaceuticals, Inc STABLE SOLUTION FOR PARENTERAL INJECTION AND MANUFACTURING METHOD OF IT
KR102007057B1 (en) 2011-10-31 2019-08-02 엑스에리스 파머수티클스, 인크. Formulations for the treatment of diabetes
WO2013067281A1 (en) 2011-11-04 2013-05-10 Battelle Memorial Institute Processes for producing protein microparticles
CN108187043A (en) 2012-05-18 2018-06-22 基因泰克公司 High-concentration monoclonal antibody preparaton
PT107846B (en) * 2014-08-01 2019-03-22 Hovione Farm S A Production of Amorphous Solid Dispersion Nanoparticles by Controlled Co-Precipitation
EP3658612A4 (en) 2017-07-25 2021-06-02 Elektrofi, Inc. Formation of particles including agents
EP3459529A1 (en) 2017-09-20 2019-03-27 Tillotts Pharma Ag Preparation of sustained release solid dosage forms comprising antibodies by spray drying
WO2019226969A1 (en) 2018-05-24 2019-11-28 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
SG11202107901QA (en) 2019-02-05 2021-08-30 Lindy Biosciences Inc Isolated cell culture components and methods for isolating the same from liquid cell culture medium
AU2020344675A1 (en) * 2019-09-13 2022-03-31 Elektrofi, Inc. Compositions and methods for the delivery of therapeutic biologics for treatment of disease
AU2021257476A1 (en) 2020-04-17 2022-11-03 Elektrofi, Inc. Methods of forming particles by continuous droplet formation and dehydration

Also Published As

Publication number Publication date
CA3128204A1 (en) 2020-08-13
KR20210125032A (en) 2021-10-15
CN113661006A (en) 2021-11-16
JP2022519690A (en) 2022-03-24
US20230093954A1 (en) 2023-03-30
EP3921082A1 (en) 2021-12-15
WO2020163446A1 (en) 2020-08-13
AU2020219125A1 (en) 2021-08-12
US11795429B2 (en) 2023-10-24
US20220119760A1 (en) 2022-04-21
EP3921082A4 (en) 2022-11-02

Similar Documents

Publication Publication Date Title
EP3444332A4 (en) Medium addition kit for culturing nk cells and nk cell culturing method using kit
EP3810749A4 (en) Systems, methods and apparatus for the automated culture of cells
EP3448982A4 (en) Cell culture medium
EP3739037A4 (en) Cell culturing method and device
EP4021180A4 (en) Cell cryopreservation medium
EP4048293A4 (en) Systems and methods for cell culturing
IL286907A (en) Cryopreservation and cell culture media
EP3420072A4 (en) Cell culture medium
EP3898951A4 (en) Media and methods for differentiating natural killer cells
GB201715930D0 (en) Cell Culture Medium
EP3447118A4 (en) Cell culture vessel and usage method therefor
EP3743121A4 (en) Cell culturing device and method
SG11202012278XA (en) Cell culture system and cell culture method
SG11202107901QA (en) Isolated cell culture components and methods for isolating the same from liquid cell culture medium
EP3438237A4 (en) Cell culture vessel, support jig for cell culture vessel and cell culture method
IL290590A (en) Cell culture methods
EP3842521A4 (en) Cell culture method and cell culture apparatus
GB201909144D0 (en) Culture medium
EP3808835A4 (en) Cell culture system and cell culture method
EP4051782A4 (en) Medium and methods for culturing organoids
EP4051777A4 (en) Methods and apparatus for cell culture wellplates
EP3460050A4 (en) Cell culturing method, culture medium, and culture medium kit
EP3744824A4 (en) Carrier for cell culture and cell culture vessel
EP3730605A4 (en) Placenta-derived cell-conditioned medium for inducing dedifferentiation from somatic cell to induced pluripotent stem cell and dedifferentiation-inducing method using same
EP3741838A4 (en) Cell culture device and cell culture method